Ocugen (OCGN) Enterprise Value (2014 - 2025)
Ocugen (OCGN) posted Enterprise Value of -$37.8 million for Q1 2025, down 140.81% on a QoQ basis from -$15.7 million in Q2 2024, and down 43.32% year-over-year from -$66.7 million in Q1 2024.
Ocugen (OCGN) Enterprise Value (2014 - 2025) Analysis & Trends
Ocugen's Enterprise Value history runs 12 years deep, the most recent figure standing at -$37.8 million for Q1 2025.
- Quarterly Enterprise Value fell 43.32% year-over-year to -$37.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$37.8 million (down 43.32% YoY) and the FY2023 annual result came in at -$39.5 million, up 56.6% from the prior year.
- Enterprise Value was -$37.8 million for Q1 2025 at Ocugen, down from -$15.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$15.7 million in Q2 2024 and bottomed at -$129.8 million in Q1 2022.
- A 5-year average of -$75.7 million and a median of -$76.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value sank 1459.04% — and 2024, when it jumped 77.76%.
- Ocugen's Enterprise Value stood at -$95.0 million in 2021, then increased by 4.24% to -$90.9 million in 2022, then soared by 56.6% to -$39.5 million in 2023, then surged by 60.22% to -$15.7 million in 2024, then plunged by 140.81% to -$37.8 million in 2025.
- Business Quant data shows OCGN's Enterprise Value at -$37.8 million in Q1 2025, -$15.7 million in Q2 2024, and -$26.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -37.80 Mn |
| Jun 30, 2024 | -15.70 Mn |
| Mar 31, 2024 | -26.38 Mn |
| Dec 31, 2023 | -39.46 Mn |
| Sep 30, 2023 | -53.48 Mn |
| Jun 30, 2023 | -70.58 Mn |
| Mar 31, 2023 | -76.72 Mn |
| Dec 31, 2022 | -90.93 Mn |
| Sep 30, 2022 | -101.60 Mn |
| Jun 30, 2022 | -115.01 Mn |
| Mar 31, 2022 | -129.77 Mn |
| Dec 31, 2021 | -94.96 Mn |
| Sep 30, 2021 | -112.34 Mn |
| Jun 30, 2021 | -120.63 Mn |
| Mar 31, 2021 | -49.78 Mn |
| Dec 31, 2020 | -24.04 Mn |
| Sep 30, 2020 | -19.11 Mn |
| Jun 30, 2020 | -14.97 Mn |
| Mar 31, 2020 | -3.19 Mn |
| Dec 31, 2019 | -7.44 Mn |